19
Views
40
CrossRef citations to date
0
Altmetric
Original Article

Effect of Erythromycin Administration on Upper Gastrointestinal Motility in Scleroderma Patients

, , , , , , & show all
Pages 807-813 | Received 19 Nov 1993, Accepted 07 Feb 1994, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shamaila Butt & Anton Emmanuel. (2013) Systemic sclerosis and the gut. Expert Review of Gastroenterology & Hepatology 7:4, pages 331-339.
Read now

Articles from other publishers (39)

A. Renaud, A. Jirka, C. Durant, J. Connault, O. Espitia, C. Takoudju & C. Agard. (2023) Atteinte digestive de la sclérodermie systémique. La Revue de Médecine Interne 44:8, pages 410-422.
Crossref
Sergio J. Bardaro, Alfredo D. Guerron, John Romanelli, Ian Soriano, Keith King, Karen E. Gibbs, Anthony Petrick, Emanuele Lo Menzo, Raul Rosenthal, Colleen Kennedy, Victoria Gershuni, Shaun Daly, Adolfo Leyva-Alvizo, Michael Tran, Vasanth Stalin, Shanu Kothari & Ranjan Sudan. (2023) Gastroparesis: an evidence-based review for the bariatric and foregut surgeon. Surgery for Obesity and Related Diseases 19:5, pages 403-420.
Crossref
Alannah Quinlivan, Zsuzsanna H. McMahan, Eun Bong Lee & Mandana Nikpour. (2023) Gastrointestinal Tract Considerations Part I. Rheumatic Disease Clinics of North America 49:2, pages 295-318.
Crossref
Nitin K. Ahuja & John O. Clarke. (2021) Scleroderma and the Esophagus. Gastroenterology Clinics of North America 50:4, pages 905-918.
Crossref
Adan Luquez-Mindiola, Alexis Javier Atuesta & Andres Jose Gómez-Aldana. (2021) Gastrointestinal manifestations of systemic sclerosis: An updated review. World Journal of Clinical Cases 9:22, pages 6201-6217.
Crossref
John O. Clarke. 2021. The Esophagus. The Esophagus 312 332 .
Liz Febo-Rodriguez & Robert J. Shulman. 2021. Gastroparesis. Gastroparesis 291 307 .
Baha Moshiree & Yellowlees Douglas. 2021. Gastroparesis. Gastroparesis 19 33 .
Jose Luis Tandaipan & Iván Castellví. (2020) Esclerosis sistémica y participación gastrointestinal. Revista Colombiana de Reumatología 27, pages 44-54.
Crossref
Jose Luis Tandaipan & Ivan Castellví. (2020) Systemic sclerosis and gastrointestinal involvement. Revista Colombiana de Reumatología (English Edition) 27, pages 44-54.
Crossref
Liz Febo‐Rodriguez, Bruno P. Chumpitazi & Robert J. Shulman. (2019) Childhood gastroparesis is a unique entity in need of further investigation. Neurogastroenterology & Motility 32:3.
Crossref
Eveline Deloose, Wout Verbeure, Inge Depoortere & Jan Tack. (2019) Motilin: from gastric motility stimulation to hunger signalling. Nature Reviews Endocrinology 15:4, pages 238-250.
Crossref
John B. Miller, Nisarg Gandhi, John Clarke & Zsuzsanna McMahan. (2018) Gastrointestinal Involvement in Systemic Sclerosis. JCR: Journal of Clinical Rheumatology 24:6, pages 328-337.
Crossref
Yoshihide Asano, Masatoshi Jinnin, Yasushi Kawaguchi, Masataka Kuwana, Daisuke Goto, Shinichi Sato, Kazuhiko Takehara, Masaru Hatano, Manabu Fujimoto, Naoki Mugii & Hironobu Ihn. (2018) Diagnostic criteria, severity classification and guidelines of systemic sclerosis. The Journal of Dermatology 45:6, pages 633-691.
Crossref
Julia Spierings, Femke C. van Rhijn-Brouwer & Jacob M. van Laar. 2018. The Microbiome in Rheumatic Diseases and Infection. The Microbiome in Rheumatic Diseases and Infection 337 346 .
John O. Clarke & John E. Pandolfino. 2017. Scleroderma. Scleroderma 427 441 .
M. O. Becker. (2016) Systemische SkleroseSystemic sclerosis. Der Internist 57:12, pages 1155-1163.
Crossref
Lawrence Szarka. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology 1154 1195 .
Vivek Nagaraja, Zsuzsanna H. McMahan, Terri Getzug & Dinesh Khanna. (2015) Management of Gastrointestinal Involvement in Scleroderma. Current Treatment Options in Rheumatology 1:1, pages 82-105.
Crossref
G. Lux. 2015. Therapie-Handbuch Grundwerk inkl 6. Lfg.. Therapie-Handbuch Grundwerk inkl 6. Lfg. 1 2 .
Edoardo Savarino, Manuele Furnari, Nicola de Bortoli, Irene Martinucci, Giorgia Bodini, Massimo Ghio & Vincenzo Savarino. (2014) Gastrointestinal involvement in systemic sclerosis. La Presse Médicale 43:10, pages e279-e291.
Crossref
David Launay, Laurent Savale, Alice Berezne, Jérôme Le Pavec, Eric Hachulla, Luc Mouthon, Olivier Sitbon, Benoit Lambert, Marianne Gaudric, Xavier Jais, Francois Stephan, Pierre-Yves Hatron, Nicolas Lamblin, Olivier Vignaux, Vincent Cottin, Dominique Farge, Benoît Wallaert, Loic Guillevin, Gerald Simonneau, Olaf Mercier, Elie Fadel, Philippe Dartevelle, Marc Humbert & Sacha Mussot. (2014) Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group. La Presse Médicale 43:10, pages e345-e363.
Crossref
John O. Clarke & Ikuo Hirano. 2012. Scleroderma. Scleroderma 471 484 .
Adam M Deane, Robert J Fraser & Marianne J Chapman. (2009) Prokinetic drugs for feed intolerance in critical illness: current and potential therapies. Critical Care and Resuscitation 11:2, pages 132-143.
Crossref
Robyn Domsic, Kenneth Fasanella & Klaus Bielefeldt. (2007) Gastrointestinal Manifestations of Systemic Sclerosis. Digestive Diseases and Sciences 53:5, pages 1163-1174.
Crossref
Grant R. Caddy, Lawrence Moran, Andre K.H. Chong, Ashley M. Miller, Andrew C. Taylor & Paul V. Desmond. (2006) The effect of erythromycin on video capsule endoscopy intestinal-transit time. Gastrointestinal Endoscopy 63:2, pages 262-266.
Crossref
Marc A. Ritz, Marianne J. Chapman, Robert J. Fraser, Mark E. Finnis, Ross N. Butler, Patricia Cmielewski, Geoffrey P. Davidson & Deborah Rea. (2005) Erythromycin dose of 70 mg accelerates gastric emptying as effectively as 200 mg in the critically ill. Intensive Care Medicine 31:7, pages 949-954.
Crossref
Rainer Linke, Matthias Meier, Wolfgang Muenzing, Christian Folwaczny, Oliver Schnell & Klaus Tatsch. (2005) Prokinetic therapy: What can be measured by gastric scintigraphy?. Nuclear Medicine Communications 26:6, pages 527-533.
Crossref
Kalyani Maganti, Kingsley Onyemere & Michael P. Jones. (2003) Oral erythromycin and symptomatic relief of gastroparesis: a systematic review. The American Journal of Gastroenterology 98:2, pages 259-263.
Crossref
Monica Acalovschi, Dan L Dumitrascu & Claudia Hagiu. (2002) Oral clarithromycin enhances gallbladder emptying induced by a mixed meal in healthy subjects. European Journal of Internal Medicine 13:2, pages 104-107.
Crossref
Eamonn M.M. Quigley, Wiliam L. Hasler & Henry P. Parkman. (2001) AGA technical review on nausea and vomiting. Gastroenterology 120:1, pages 263-286.
Crossref
P. Portincasa, A. Colecchia, A. Di Ciaula, A. Larocca, M. Muraca, G. Palasciano, E. Roda & D. Festi. (2000) Standards for diagnosis gastrointestinal motility disorders. Section: ultrasonography position statement from the Gruppo Italiano di Studio Motilità Apparato Digerente (GISMAD). Digestive and Liver Disease 32:2, pages 160-172.
Crossref
Maria Helena I Lopes, Eduardo Ludwig, Beatriz B do Amaral, Carlos F Francisconi & Carlos A von Mühlen. (1999) Motor Activity of The Gallbladder in Systemic Sclerosis. American Journal of Gastroenterology 94:12, pages 3487-3491.
Crossref
Jon S Thompson & Eamonn M.M Quigley. (1999) Prokinetic agents in the surgical patient. The American Journal of Surgery 177:6, pages 508-514.
Crossref
Eamonn M. M. Quigley. (1999) Chronic intestinal pseudo-obstruction. Current Treatment Options in Gastroenterology 2:3, pages 239-250.
Crossref
Hyo Jin Park, Jun Keun Jung, Kyung Soon Song, Sang In Lee, Zen Itoh & In Suh Park. (1997) Effect of erythromycin on gastric emptying in healthy individuals assessed by radio-opaque markers and plasma acetaminophen levels. Journal of Gastroenterology 32:6, pages 734-739.
Crossref
Zen Itoh. (1997) Motilin and Clinical Application. Peptides 18:4, pages 593-608.
Crossref
Janet E. Pope. (1996) TREATMENT OF SYSTEMIC SCLEROSIS. Rheumatic Disease Clinics of North America 22:4, pages 893-907.
Crossref
G. Lock, M. Zeuner, M. Kammerl, B. Lang, J. Schölmerich & A. Holstege. (1996) Gallbladder motility in systemic sclerosis. Rheumatology International 16:2, pages 61-65.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.